

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.60958076 |
| 2 | auditory behavior (GO:0031223) | 5.18085996 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.08276921 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.84791344 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.80576605 |
| 6 | vocalization behavior (GO:0071625) | 4.71629303 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.71125466 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.67104864 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.67104864 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.67104864 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.67104864 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.67104864 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.67104864 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.64158011 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 4.56933043 |
| 16 | glutamate secretion (GO:0014047) | 4.56210229 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.55949976 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.55949976 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.44366416 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.37446480 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.37274678 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.36643269 |
| 23 | protein localization to synapse (GO:0035418) | 4.35134224 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30523261 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.30280590 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.26189810 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.23600524 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.17977656 |
| 29 | response to auditory stimulus (GO:0010996) | 4.17246472 |
| 30 | mechanosensory behavior (GO:0007638) | 4.14299078 |
| 31 | startle response (GO:0001964) | 4.11443422 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.96675592 |
| 33 | glutamate receptor signaling pathway (GO:0007215) | 3.94547148 |
| 34 | synaptic transmission, glutamatergic (GO:0035249) | 3.92155662 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.90753489 |
| 36 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.90494025 |
| 37 | layer formation in cerebral cortex (GO:0021819) | 3.87999486 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.84755686 |
| 39 | regulation of synaptic vesicle transport (GO:1902803) | 3.83808968 |
| 40 | transmission of nerve impulse (GO:0019226) | 3.80238467 |
| 41 | innervation (GO:0060384) | 3.79385949 |
| 42 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.74567355 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.74022526 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.73875668 |
| 45 | presynaptic membrane assembly (GO:0097105) | 3.71633688 |
| 46 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.70677062 |
| 47 | neurotransmitter secretion (GO:0007269) | 3.69968221 |
| 48 | neuron-neuron synaptic transmission (GO:0007270) | 3.68648412 |
| 49 | L-amino acid import (GO:0043092) | 3.65937055 |
| 50 | detection of other organism (GO:0098543) | 3.59682136 |
| 51 | presynaptic membrane organization (GO:0097090) | 3.58460819 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.58170109 |
| 53 | exploration behavior (GO:0035640) | 3.56947850 |
| 54 | cellular extravasation (GO:0045123) | 3.52280366 |
| 55 | neuron recognition (GO:0008038) | 3.50970774 |
| 56 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.50178852 |
| 57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.49445735 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.49090220 |
| 59 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48988350 |
| 60 | synaptic vesicle endocytosis (GO:0048488) | 3.47610349 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.46054982 |
| 62 | microglial cell activation (GO:0001774) | 3.45449596 |
| 63 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44870310 |
| 64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.43783351 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.41875166 |
| 66 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41771287 |
| 67 | gamma-aminobutyric acid transport (GO:0015812) | 3.40446845 |
| 68 | long-term memory (GO:0007616) | 3.36547792 |
| 69 | neuronal ion channel clustering (GO:0045161) | 3.35370242 |
| 70 | regulation of postsynaptic membrane potential (GO:0060078) | 3.33885816 |
| 71 | regulation of synapse structural plasticity (GO:0051823) | 3.32946264 |
| 72 | axonal fasciculation (GO:0007413) | 3.27970765 |
| 73 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.27671893 |
| 74 | central nervous system myelination (GO:0022010) | 3.24064861 |
| 75 | axon ensheathment in central nervous system (GO:0032291) | 3.24064861 |
| 76 | regulation of synaptic plasticity (GO:0048167) | 3.23580571 |
| 77 | proline transport (GO:0015824) | 3.21805478 |
| 78 | macrophage activation (GO:0042116) | 3.20750993 |
| 79 | synapse assembly (GO:0007416) | 3.20069357 |
| 80 | neutrophil activation (GO:0042119) | 3.19944249 |
| 81 | regulation of neurotransmitter secretion (GO:0046928) | 3.19800692 |
| 82 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18631952 |
| 83 | neurotransmitter transport (GO:0006836) | 3.17512468 |
| 84 | response to host immune response (GO:0052572) | 3.17274011 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17274011 |
| 86 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.16301833 |
| 87 | detection of bacterium (GO:0016045) | 3.15551148 |
| 88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15179422 |
| 89 | long-term synaptic potentiation (GO:0060291) | 3.12401723 |
| 90 | response to peptidoglycan (GO:0032494) | 3.11325478 |
| 91 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09957175 |
| 92 | neuromuscular process controlling balance (GO:0050885) | 3.09299397 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.08219716 |
| 94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07963529 |
| 95 | detection of biotic stimulus (GO:0009595) | 3.07663939 |
| 96 | response to host (GO:0075136) | 3.06233521 |
| 97 | response to host defenses (GO:0052200) | 3.06233521 |
| 98 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.06233521 |
| 99 | cellular potassium ion homeostasis (GO:0030007) | 3.05996857 |
| 100 | dendrite morphogenesis (GO:0048813) | 3.05174171 |
| 101 | negative regulation of neurotransmitter transport (GO:0051589) | 3.04389815 |
| 102 | membrane hyperpolarization (GO:0060081) | 3.03902859 |
| 103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.03295883 |
| 104 | cerebellar granule cell differentiation (GO:0021707) | 3.02121819 |
| 105 | regulation of vesicle fusion (GO:0031338) | 3.01733102 |
| 106 | synapse organization (GO:0050808) | 3.01598681 |
| 107 | dendritic spine organization (GO:0097061) | 3.01167216 |
| 108 | neutrophil mediated immunity (GO:0002446) | 3.00625300 |
| 109 | glycine transport (GO:0015816) | 3.00313273 |
| 110 | leukocyte aggregation (GO:0070486) | 3.00133561 |
| 111 | adult walking behavior (GO:0007628) | 2.99279955 |
| 112 | positive regulation of receptor recycling (GO:0001921) | 2.97352725 |
| 113 | cochlea development (GO:0090102) | 2.96611395 |
| 114 | membrane depolarization during action potential (GO:0086010) | 2.95740314 |
| 115 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95717486 |
| 116 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95476569 |
| 117 | mating behavior (GO:0007617) | 2.95132565 |
| 118 | postsynaptic membrane organization (GO:0001941) | 2.93681514 |
| 119 | membrane depolarization (GO:0051899) | 2.92455221 |
| 120 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.91858898 |
| 121 | vesicle transport along microtubule (GO:0047496) | 2.91477423 |
| 122 | positive regulation of synapse maturation (GO:0090129) | 2.91256714 |
| 123 | regulation of neurotransmitter transport (GO:0051588) | 2.91130413 |
| 124 | neuromuscular process (GO:0050905) | 2.89748759 |
| 125 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.89469218 |
| 126 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.89238219 |
| 127 | nerve growth factor signaling pathway (GO:0038180) | 2.86242820 |
| 128 | regulation of dendritic spine development (GO:0060998) | 2.85533372 |
| 129 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.85498845 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84610288 |
| 131 | granulocyte activation (GO:0036230) | 2.84386674 |
| 132 | regulation of mast cell degranulation (GO:0043304) | 2.83685429 |
| 133 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.83181231 |
| 134 | regulation of neurotransmitter levels (GO:0001505) | 2.83027107 |
| 135 | regulation of leukocyte degranulation (GO:0043300) | 2.82109590 |
| 136 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.82069181 |
| 137 | regulation of macrophage cytokine production (GO:0010935) | 2.81718632 |
| 138 | learning (GO:0007612) | 2.80564982 |
| 139 | response to interleukin-15 (GO:0070672) | 2.80446195 |
| 140 | amino acid import (GO:0043090) | 2.77580413 |
| 141 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.77285465 |
| 142 | cell migration in hindbrain (GO:0021535) | 2.77245360 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76658997 |
| 144 | regulation of platelet aggregation (GO:0090330) | 2.76371131 |
| 145 | negative regulation of interleukin-12 production (GO:0032695) | 2.76188010 |
| 146 | suckling behavior (GO:0001967) | 2.75425811 |
| 147 | behavioral response to cocaine (GO:0048148) | 2.74106165 |
| 148 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.73106895 |
| 149 | activation of protein kinase A activity (GO:0034199) | 2.72567221 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72118321 |
| 151 | positive regulation of Rap GTPase activity (GO:0032854) | 2.72043974 |
| 152 | regulation of regulated secretory pathway (GO:1903305) | 2.71333972 |
| 153 | regulation of ARF protein signal transduction (GO:0032012) | 2.70042977 |
| 154 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.69913888 |
| 155 | regulation of synaptic transmission (GO:0050804) | 2.69498229 |
| 156 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69235224 |
| 157 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67636623 |
| 158 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.66426438 |
| 159 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63708708 |
| 160 | myeloid cell activation involved in immune response (GO:0002275) | 2.63593819 |
| 161 | germinal center formation (GO:0002467) | 2.63150657 |
| 162 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.61512593 |
| 163 | myeloid leukocyte mediated immunity (GO:0002444) | 2.58600933 |
| 164 | positive regulation of mast cell activation (GO:0033005) | 2.53704849 |
| 165 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52257839 |
| 166 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51830527 |
| 167 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.49870148 |
| 168 | respiratory burst (GO:0045730) | 2.45789314 |
| 169 | negative regulation of type 2 immune response (GO:0002829) | 2.45451938 |
| 170 | cellular response to interleukin-15 (GO:0071350) | 2.43668161 |
| 171 | signal complex assembly (GO:0007172) | 2.41155189 |
| 172 | negative regulation of inclusion body assembly (GO:0090084) | 2.40263229 |
| 173 | regulation of Rap GTPase activity (GO:0032317) | 2.39958782 |
| 174 | regulation of beta-amyloid formation (GO:1902003) | 2.39605384 |
| 175 | protein localization to endosome (GO:0036010) | 2.39297340 |
| 176 | cellular response to epinephrine stimulus (GO:0071872) | 2.39100068 |
| 177 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.38842234 |
| 178 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.38842234 |
| 179 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.38626382 |
| 180 | regulation of ARF GTPase activity (GO:0032312) | 2.37393682 |
| 181 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.29300535 |
| 182 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.27953466 |
| 183 | response to muramyl dipeptide (GO:0032495) | 2.27786341 |
| 184 | regulation of mast cell activation (GO:0033003) | 2.27483813 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.24923611 |
| 186 | actin filament polymerization (GO:0030041) | 2.24149031 |
| 187 | regulation of cellular amide metabolic process (GO:0034248) | 2.23365700 |
| 188 | negative regulation of T cell mediated immunity (GO:0002710) | 2.22407067 |
| 189 | B cell receptor signaling pathway (GO:0050853) | 2.21580676 |
| 190 | positive regulation of regulated secretory pathway (GO:1903307) | 2.19042647 |
| 191 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.18180679 |
| 192 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.17431342 |
| 193 | response to type I interferon (GO:0034340) | 2.17193609 |
| 194 | cellular response to type I interferon (GO:0071357) | 2.16749591 |
| 195 | type I interferon signaling pathway (GO:0060337) | 2.16749591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.84374707 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80709793 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90826578 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86869974 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77927808 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70035354 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49466596 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45845539 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44275045 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44275045 |
| 11 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.40101183 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39206785 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.37149974 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36128710 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35367333 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.32274665 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30447547 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28444886 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.27491827 |
| 20 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.25883779 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.25397385 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.23637864 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17565946 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13933502 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06883170 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05274203 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03853822 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02493733 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02170889 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01791163 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.93814560 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90949376 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90877290 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87455267 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87261168 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87246462 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.87025402 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86898315 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85826371 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84577137 |
| 41 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.84217852 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81199025 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77436821 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74776166 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72837380 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72445093 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70136382 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69629135 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67465102 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67342294 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67199211 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67021192 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64131764 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63464605 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.63091072 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60175753 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58298275 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56432389 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54939277 |
| 60 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.54127764 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.54102504 |
| 62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50306265 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48018145 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47102239 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46768671 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46657001 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45613061 |
| 68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45186902 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45028370 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44892112 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43331340 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42380406 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40389396 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40239111 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39893488 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39767462 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38827378 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38543818 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38513099 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37938088 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37159607 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36831445 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36801637 |
| 84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35981274 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35650699 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35209425 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33701288 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32817002 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32293234 |
| 90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31583936 |
| 91 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31488445 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30489446 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29460663 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27687600 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25811336 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25487973 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24707044 |
| 98 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24043787 |
| 99 | AR_19668381_ChIP-Seq_PC3_Human | 1.23804432 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23341998 |
| 101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23303882 |
| 102 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22695439 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21003816 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20841255 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20178105 |
| 106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19904550 |
| 107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19874237 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19409324 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19393470 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19183401 |
| 111 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19011949 |
| 112 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18986287 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18878390 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18216995 |
| 115 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17343056 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17331278 |
| 117 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16950381 |
| 118 | MAF_26560356_Chip-Seq_TH1_Human | 1.16363675 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15679148 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14256743 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14153615 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13674654 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13368964 |
| 124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13290390 |
| 125 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12620165 |
| 126 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11982223 |
| 127 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11106544 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08475199 |
| 129 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07785845 |
| 130 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07214674 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06734078 |
| 132 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06706312 |
| 133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06505278 |
| 134 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05674904 |
| 135 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05404230 |
| 136 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04308904 |
| 137 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03772823 |
| 138 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02996381 |
| 139 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02871120 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02509115 |
| 141 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02295497 |
| 142 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02266836 |
| 143 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01903404 |
| 144 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.00957848 |
| 145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00627702 |
| 146 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00304133 |
| 147 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00095939 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99720149 |
| 149 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99712373 |
| 150 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99375130 |
| 151 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99242765 |
| 152 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98846020 |
| 153 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98065436 |
| 154 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97876337 |
| 155 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97169618 |
| 156 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96933549 |
| 157 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96546496 |
| 158 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96235350 |
| 159 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95766573 |
| 160 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95766573 |
| 161 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95737424 |
| 162 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95377399 |
| 163 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94329969 |
| 164 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94271714 |
| 165 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93785888 |
| 166 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93429144 |
| 167 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93429144 |
| 168 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93414926 |
| 169 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92533545 |
| 170 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91404079 |
| 171 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90746943 |
| 172 | JUN_21703547_ChIP-Seq_K562_Human | 0.89764677 |
| 173 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89095977 |
| 174 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88477748 |
| 175 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.88123805 |
| 176 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86915120 |
| 177 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86403537 |
| 178 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85553458 |
| 179 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84310162 |
| 180 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.83607879 |
| 181 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83193550 |
| 182 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82465620 |
| 183 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82237119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.44367170 |
| 2 | MP0003724_increased_susceptibility_to | 4.90179114 |
| 3 | MP0003880_abnormal_central_pattern | 4.74039550 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.87262120 |
| 5 | MP0004270_analgesia | 3.74223418 |
| 6 | MP0003303_peritoneal_inflammation | 3.63324743 |
| 7 | MP0009745_abnormal_behavioral_response | 3.25056765 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.14576304 |
| 9 | MP0002064_seizures | 3.12997654 |
| 10 | MP0003436_decreased_susceptibility_to | 3.12981689 |
| 11 | MP0001968_abnormal_touch/_nociception | 3.08850672 |
| 12 | MP0009046_muscle_twitch | 3.06011582 |
| 13 | MP0008260_abnormal_autophagy | 2.91381392 |
| 14 | MP0001486_abnormal_startle_reflex | 2.87747264 |
| 15 | MP0002736_abnormal_nociception_after | 2.75965489 |
| 16 | MP0002272_abnormal_nervous_system | 2.67529179 |
| 17 | MP0002822_catalepsy | 2.66421099 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.65990395 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.63840753 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.59994319 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.51281535 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.42373668 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.35798328 |
| 24 | MP0002419_abnormal_innate_immunity | 2.28579375 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.28003831 |
| 26 | MP0000778_abnormal_nervous_system | 2.11452174 |
| 27 | MP0002735_abnormal_chemical_nociception | 2.11368191 |
| 28 | MP0001958_emphysema | 2.11282107 |
| 29 | MP0003828_pulmonary_edema | 2.08892494 |
| 30 | MP0002067_abnormal_sensory_capabilities | 2.02553889 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.96411505 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.94590960 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.93457061 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.91193214 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.88834524 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.88593910 |
| 37 | MP0001970_abnormal_pain_threshold | 1.87871435 |
| 38 | MP0005451_abnormal_body_composition | 1.87856215 |
| 39 | MP0000920_abnormal_myelination | 1.87326109 |
| 40 | MP0003329_amyloid_beta_deposits | 1.87005408 |
| 41 | MP0004885_abnormal_endolymph | 1.86746818 |
| 42 | MP0005025_abnormal_response_to | 1.83324950 |
| 43 | MP0004381_abnormal_hair_follicle | 1.80610862 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.77781058 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.77424294 |
| 46 | MP0001984_abnormal_olfaction | 1.77383417 |
| 47 | MP0002184_abnormal_innervation | 1.75273910 |
| 48 | MP0008569_lethality_at_weaning | 1.75033620 |
| 49 | MP0000955_abnormal_spinal_cord | 1.68965410 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.68472089 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.66622037 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.66297860 |
| 53 | MP0004924_abnormal_behavior | 1.64158157 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.64158157 |
| 55 | MP0003045_fibrosis | 1.61918562 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.60370624 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.59934251 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.57411578 |
| 59 | MP0003690_abnormal_glial_cell | 1.56877440 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.55547169 |
| 61 | MP0004883_abnormal_blood_vessel | 1.55384610 |
| 62 | MP0003091_abnormal_cell_migration | 1.54984850 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.51656507 |
| 64 | MP0001800_abnormal_humoral_immune | 1.50465694 |
| 65 | MP0008004_abnormal_stomach_pH | 1.49322599 |
| 66 | MP0002723_abnormal_immune_serum | 1.48577771 |
| 67 | MP0004742_abnormal_vestibular_system | 1.48457222 |
| 68 | MP0000685_abnormal_immune_system | 1.46314482 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 1.46024179 |
| 70 | MP0002420_abnormal_adaptive_immunity | 1.45456746 |
| 71 | MP0006082_CNS_inflammation | 1.44800666 |
| 72 | MP0001905_abnormal_dopamine_level | 1.44253368 |
| 73 | MP0003633_abnormal_nervous_system | 1.44114427 |
| 74 | MP0001819_abnormal_immune_cell | 1.42857935 |
| 75 | MP0001851_eye_inflammation | 1.42378751 |
| 76 | MP0003787_abnormal_imprinting | 1.41051299 |
| 77 | MP0009278_abnormal_bone_marrow | 1.40970264 |
| 78 | MP0001529_abnormal_vocalization | 1.40166167 |
| 79 | MP0004947_skin_inflammation | 1.40133930 |
| 80 | MP0002229_neurodegeneration | 1.38772856 |
| 81 | MP0004858_abnormal_nervous_system | 1.38296373 |
| 82 | MP0005387_immune_system_phenotype | 1.36949078 |
| 83 | MP0001790_abnormal_immune_system | 1.36949078 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.31241268 |
| 85 | MP0009785_altered_susceptibility_to | 1.31079336 |
| 86 | MP0002452_abnormal_antigen_presenting | 1.30505261 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.29113097 |
| 88 | MP0003631_nervous_system_phenotype | 1.29099666 |
| 89 | MP0004142_abnormal_muscle_tone | 1.27443426 |
| 90 | MP0005058_abnormal_lysosome_morphology | 1.27055625 |
| 91 | MP0005164_abnormal_response_to | 1.24944458 |
| 92 | MP0003634_abnormal_glial_cell | 1.22878155 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 1.22268449 |
| 94 | MP0003632_abnormal_nervous_system | 1.18637964 |
| 95 | MP0003879_abnormal_hair_cell | 1.15848504 |
| 96 | MP0003279_aneurysm | 1.15656383 |
| 97 | MP0002152_abnormal_brain_morphology | 1.15191881 |
| 98 | MP0001485_abnormal_pinna_reflex | 1.12206115 |
| 99 | MP0001963_abnormal_hearing_physiology | 1.09425634 |
| 100 | MP0005409_darkened_coat_color | 1.08649959 |
| 101 | MP0002405_respiratory_system_inflammati | 1.07750889 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 1.05694711 |
| 103 | MP0002332_abnormal_exercise_endurance | 1.05467153 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 1.04460824 |
| 105 | MP0005394_taste/olfaction_phenotype | 1.04335822 |
| 106 | MP0005499_abnormal_olfactory_system | 1.04335822 |
| 107 | MP0002132_abnormal_respiratory_system | 1.03808955 |
| 108 | MP0006276_abnormal_autonomic_nervous | 1.03378943 |
| 109 | MP0002909_abnormal_adrenal_gland | 1.03158995 |
| 110 | MP0002133_abnormal_respiratory_system | 1.01068478 |
| 111 | MP0005388_respiratory_system_phenotype | 1.01068478 |
| 112 | MP0002752_abnormal_somatic_nervous | 1.00803897 |
| 113 | MP0005166_decreased_susceptibility_to | 1.00679158 |
| 114 | MP0002148_abnormal_hypersensitivity_rea | 0.99579840 |
| 115 | MP0001177_atelectasis | 0.98505437 |
| 116 | MP0000716_abnormal_immune_system | 0.97338454 |
| 117 | MP0002398_abnormal_bone_marrow | 0.97084051 |
| 118 | MP0003866_abnormal_defecation | 0.96398795 |
| 119 | MP0000858_altered_metastatic_potential | 0.95919544 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.95327447 |
| 121 | MP0005171_absent_coat_pigmentation | 0.94682178 |
| 122 | MP0005390_skeleton_phenotype | 0.94247243 |
| 123 | MP0005671_abnormal_response_to | 0.93920498 |
| 124 | MP0005076_abnormal_cell_differentiation | 0.92626727 |
| 125 | MP0002090_abnormal_vision | 0.89799461 |
| 126 | MP0000343_altered_response_to | 0.89338814 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.88736642 |
| 128 | MP0004484_altered_response_of | 0.88376502 |
| 129 | MP0008438_abnormal_cutaneous_collagen | 0.86971488 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.86915841 |
| 131 | MP0000631_abnormal_neuroendocrine_gland | 0.85115433 |
| 132 | MP0003763_abnormal_thymus_physiology | 0.84533785 |
| 133 | MP0009764_decreased_sensitivity_to | 0.83510515 |
| 134 | MP0003122_maternal_imprinting | 0.82704775 |
| 135 | MP0001849_ear_inflammation | 0.82657492 |
| 136 | MP0000604_amyloidosis | 0.81850153 |
| 137 | MP0005023_abnormal_wound_healing | 0.80069227 |
| 138 | MP0000249_abnormal_blood_vessel | 0.79399615 |
| 139 | MP0005253_abnormal_eye_physiology | 0.79183197 |
| 140 | MP0010155_abnormal_intestine_physiology | 0.78407372 |
| 141 | MP0001188_hyperpigmentation | 0.78405358 |
| 142 | MP0008874_decreased_physiological_sensi | 0.77965485 |
| 143 | MP0003448_altered_tumor_morphology | 0.77464601 |
| 144 | MP0004130_abnormal_muscle_cell | 0.75249634 |
| 145 | MP0005397_hematopoietic_system_phenotyp | 0.75175725 |
| 146 | MP0001545_abnormal_hematopoietic_system | 0.75175725 |
| 147 | MP0000026_abnormal_inner_ear | 0.74611002 |
| 148 | MP0008961_abnormal_basal_metabolism | 0.73344947 |
| 149 | MP0000569_abnormal_digit_pigmentation | 0.73142366 |
| 150 | MP0000751_myopathy | 0.70951676 |
| 151 | MP0005248_abnormal_Harderian_gland | 0.70654587 |
| 152 | MP0005410_abnormal_fertilization | 0.70110540 |
| 153 | MP0004085_abnormal_heartbeat | 0.69410639 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.68681950 |
| 155 | MP0003453_abnormal_keratinocyte_physiol | 0.68245696 |
| 156 | MP0002722_abnormal_immune_system | 0.67941512 |
| 157 | MP0001346_abnormal_lacrimal_gland | 0.67498240 |
| 158 | MP0003075_altered_response_to | 0.66085760 |
| 159 | MP0003172_abnormal_lysosome_physiology | 0.65181921 |
| 160 | MP0003861_abnormal_nervous_system | 0.64825192 |
| 161 | MP0003137_abnormal_impulse_conducting | 0.62271107 |
| 162 | MP0005535_abnormal_body_temperature | 0.61684793 |
| 163 | MP0005167_abnormal_blood-brain_barrier | 0.60126537 |
| 164 | MP0004510_myositis | 0.60011700 |
| 165 | MP0005195_abnormal_posterior_eye | 0.58994204 |
| 166 | MP0003136_yellow_coat_color | 0.56246390 |
| 167 | MP0006072_abnormal_retinal_apoptosis | 0.56093503 |
| 168 | MP0010386_abnormal_urinary_bladder | 0.53935939 |
| 169 | MP0001299_abnormal_eye_distance/ | 0.53385364 |
| 170 | MP0010769_abnormal_survival | 0.53329199 |
| 171 | MP0004043_abnormal_pH_regulation | 0.52931993 |
| 172 | MP0010770_preweaning_lethality | 0.52625406 |
| 173 | MP0002082_postnatal_lethality | 0.52625406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.25570877 |
| 2 | Myokymia (HP:0002411) | 6.09996634 |
| 3 | Focal seizures (HP:0007359) | 5.19261986 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.64090297 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.57895454 |
| 6 | Atonic seizures (HP:0010819) | 4.34234536 |
| 7 | Visual hallucinations (HP:0002367) | 4.17104984 |
| 8 | Febrile seizures (HP:0002373) | 4.09189792 |
| 9 | Myositis (HP:0100614) | 4.07554421 |
| 10 | Orchitis (HP:0100796) | 4.06897482 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.82380243 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.75539006 |
| 13 | Abnormality of the corticospinal tract (HP:0002492) | 3.72061221 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.70032166 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.66938454 |
| 16 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.66082072 |
| 17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.66082072 |
| 18 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.64558180 |
| 19 | Optic neuritis (HP:0100653) | 3.63655077 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.63655077 |
| 21 | Hyperventilation (HP:0002883) | 3.59981252 |
| 22 | Action tremor (HP:0002345) | 3.56345343 |
| 23 | Absence seizures (HP:0002121) | 3.54697704 |
| 24 | Neurofibrillary tangles (HP:0002185) | 3.54502636 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.51605464 |
| 26 | Peritonitis (HP:0002586) | 3.47653815 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.42410560 |
| 28 | Broad-based gait (HP:0002136) | 3.39906308 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 3.38360890 |
| 30 | * Spastic gait (HP:0002064) | 3.35464094 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 3.30270852 |
| 32 | Prolonged bleeding time (HP:0003010) | 3.25476451 |
| 33 | * Dysmetria (HP:0001310) | 3.25049262 |
| 34 | Dialeptic seizures (HP:0011146) | 3.25025567 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 3.17200464 |
| 36 | Ankle clonus (HP:0011448) | 3.15867800 |
| 37 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.14673383 |
| 38 | Obstructive sleep apnea (HP:0002870) | 3.06717274 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02987881 |
| 40 | Gingivitis (HP:0000230) | 3.00559559 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.97509328 |
| 42 | Dysdiadochokinesis (HP:0002075) | 2.96637239 |
| 43 | Urinary urgency (HP:0000012) | 2.94773082 |
| 44 | Gingival bleeding (HP:0000225) | 2.90055302 |
| 45 | Intention tremor (HP:0002080) | 2.88649558 |
| 46 | Termporal pattern (HP:0011008) | 2.87674524 |
| 47 | Insidious onset (HP:0003587) | 2.87674524 |
| 48 | Postural instability (HP:0002172) | 2.84500121 |
| 49 | Depression (HP:0000716) | 2.82696980 |
| 50 | Aqueductal stenosis (HP:0002410) | 2.80641222 |
| 51 | Stomatitis (HP:0010280) | 2.77796699 |
| 52 | Poor eye contact (HP:0000817) | 2.74924098 |
| 53 | Difficulty running (HP:0009046) | 2.74402239 |
| 54 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.72842935 |
| 55 | Scanning speech (HP:0002168) | 2.72011428 |
| 56 | Lower limb muscle weakness (HP:0007340) | 2.72003587 |
| 57 | Truncal ataxia (HP:0002078) | 2.67363462 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.66884170 |
| 59 | Drooling (HP:0002307) | 2.66514594 |
| 60 | Excessive salivation (HP:0003781) | 2.66514594 |
| 61 | Cellulitis (HP:0100658) | 2.63899614 |
| 62 | Muscle fiber splitting (HP:0003555) | 2.60518071 |
| 63 | Epistaxis (HP:0000421) | 2.59192560 |
| 64 | Abnormal platelet volume (HP:0011876) | 2.58343689 |
| 65 | Amyloidosis (HP:0011034) | 2.57937068 |
| 66 | Absent speech (HP:0001344) | 2.55289587 |
| 67 | Anxiety (HP:0000739) | 2.54461656 |
| 68 | Episodic fever (HP:0001954) | 2.51459636 |
| 69 | Impaired social interactions (HP:0000735) | 2.47962053 |
| 70 | Abnormal social behavior (HP:0012433) | 2.47962053 |
| 71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39171722 |
| 72 | Amblyopia (HP:0000646) | 2.38325698 |
| 73 | Hyporeflexia of lower limbs (HP:0002600) | 2.37034878 |
| 74 | Chest pain (HP:0100749) | 2.36613793 |
| 75 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36213687 |
| 76 | Mutism (HP:0002300) | 2.33829655 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.33610858 |
| 78 | Epileptiform EEG discharges (HP:0011182) | 2.33356859 |
| 79 | Hemiparesis (HP:0001269) | 2.32626376 |
| 80 | Menorrhagia (HP:0000132) | 2.32490893 |
| 81 | Insomnia (HP:0100785) | 2.31834337 |
| 82 | Central scotoma (HP:0000603) | 2.30273663 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.29538912 |
| 84 | Blue irides (HP:0000635) | 2.29152908 |
| 85 | Slow saccadic eye movements (HP:0000514) | 2.27170057 |
| 86 | Sensory axonal neuropathy (HP:0003390) | 2.26923129 |
| 87 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23733850 |
| 88 | Hypochromic microcytic anemia (HP:0004840) | 2.23513167 |
| 89 | Recurrent fungal infections (HP:0002841) | 2.23004633 |
| 90 | Recurrent skin infections (HP:0001581) | 2.21948267 |
| 91 | Impaired vibratory sensation (HP:0002495) | 2.21864978 |
| 92 | Genetic anticipation (HP:0003743) | 2.21227569 |
| 93 | Aortic aneurysm (HP:0004942) | 2.19275040 |
| 94 | Stereotypic behavior (HP:0000733) | 2.18644801 |
| 95 | Onion bulb formation (HP:0003383) | 2.16590111 |
| 96 | Increased IgE level (HP:0003212) | 2.15753318 |
| 97 | Megalencephaly (HP:0001355) | 2.14654666 |
| 98 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.14603411 |
| 99 | Absent/shortened dynein arms (HP:0200106) | 2.14603411 |
| 100 | Abnormality of binocular vision (HP:0011514) | 2.13154315 |
| 101 | Diplopia (HP:0000651) | 2.13154315 |
| 102 | Widely spaced teeth (HP:0000687) | 2.13040320 |
| 103 | Bradykinesia (HP:0002067) | 2.13032007 |
| 104 | Hypsarrhythmia (HP:0002521) | 2.12527125 |
| 105 | Obstructive lung disease (HP:0006536) | 2.11801068 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11801068 |
| 107 | Arterial thrombosis (HP:0004420) | 2.11608852 |
| 108 | Torticollis (HP:0000473) | 2.10378144 |
| 109 | Abnormal eating behavior (HP:0100738) | 2.10364596 |
| 110 | Cerebral aneurysm (HP:0004944) | 2.09460036 |
| 111 | Increased mean platelet volume (HP:0011877) | 2.07536458 |
| 112 | Mediastinal lymphadenopathy (HP:0100721) | 2.05754820 |
| 113 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03410916 |
| 114 | Abnormality of the peritoneum (HP:0002585) | 2.01670269 |
| 115 | Clonus (HP:0002169) | 2.01104258 |
| 116 | Meningitis (HP:0001287) | 1.99582496 |
| 117 | Urticaria (HP:0001025) | 1.97827025 |
| 118 | Pulmonary embolism (HP:0002204) | 1.95757161 |
| 119 | Increased connective tissue (HP:0009025) | 1.95331582 |
| 120 | Purpura (HP:0000979) | 1.94930227 |
| 121 | Arterial tortuosity (HP:0005116) | 1.94363921 |
| 122 | Abnormality of the lower motor neuron (HP:0002366) | 1.93475123 |
| 123 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.93331461 |
| 124 | Aplasia of the phalanges of the hand (HP:0009802) | 1.93331461 |
| 125 | Aplasia involving bones of the extremities (HP:0009825) | 1.93331461 |
| 126 | Abnormality of salivation (HP:0100755) | 1.92797700 |
| 127 | Thickened helices (HP:0000391) | 1.92111484 |
| 128 | Fetal akinesia sequence (HP:0001989) | 1.91921677 |
| 129 | Vascular tortuosity (HP:0004948) | 1.91690246 |
| 130 | Hemoptysis (HP:0002105) | 1.91620354 |
| 131 | Impaired smooth pursuit (HP:0007772) | 1.91426096 |
| 132 | Gait imbalance (HP:0002141) | 1.91097095 |
| 133 | Petechiae (HP:0000967) | 1.90989514 |
| 134 | Protruding tongue (HP:0010808) | 1.90487288 |
| 135 | Dilatation of the ascending aorta (HP:0005111) | 1.89904499 |
| 136 | Overriding aorta (HP:0002623) | 1.88341860 |
| 137 | Decreased motor nerve conduction velocity (HP:0003431) | 1.87319087 |
| 138 | Papilledema (HP:0001085) | 1.87217860 |
| 139 | Subacute progressive viral hepatitis (HP:0006572) | 1.84985459 |
| 140 | Abnormality of macular pigmentation (HP:0008002) | 1.84815712 |
| 141 | Vasculitis (HP:0002633) | 1.83351781 |
| 142 | Ventricular fibrillation (HP:0001663) | 1.82282611 |
| 143 | Polycythemia (HP:0001901) | 1.81781150 |
| 144 | Progressive inability to walk (HP:0002505) | 1.81668324 |
| 145 | Hypochromic anemia (HP:0001931) | 1.80986439 |
| 146 | Pointed chin (HP:0000307) | 1.80613464 |
| 147 | Bowel incontinence (HP:0002607) | 1.80557275 |
| 148 | Aneurysm (HP:0002617) | 1.80489232 |
| 149 | Focal dystonia (HP:0004373) | 1.80278736 |
| 150 | Encephalitis (HP:0002383) | 1.80025342 |
| 151 | Spastic paraplegia (HP:0001258) | 1.78608853 |
| 152 | Incomplete penetrance (HP:0003829) | 1.78461718 |
| 153 | Paraplegia (HP:0010550) | 1.77913011 |
| 154 | Vertigo (HP:0002321) | 1.77440135 |
| 155 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.76958101 |
| 156 | Retinal dysplasia (HP:0007973) | 1.76347829 |
| 157 | Hemiplegia (HP:0002301) | 1.76009206 |
| 158 | * Gastroesophageal reflux (HP:0002020) | 1.75677424 |
| 159 | Bruising susceptibility (HP:0000978) | 1.75456516 |
| 160 | Psychosis (HP:0000709) | 1.75197964 |
| 161 | Severe Myopia (HP:0011003) | 1.75187558 |
| 162 | Ocular albinism (HP:0001107) | 1.74797522 |
| 163 | Metaphyseal cupping (HP:0003021) | 1.74408854 |
| 164 | Neuronal loss in central nervous system (HP:0002529) | 1.74359161 |
| 165 | Abnormality of the endocardium (HP:0004306) | 1.73459265 |
| 166 | Prolonged QT interval (HP:0001657) | 1.73332453 |
| 167 | Abnormality of saccadic eye movements (HP:0000570) | 1.72412637 |
| 168 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72086575 |
| 169 | * Gait ataxia (HP:0002066) | 1.71685495 |
| 170 | Pheochromocytoma (HP:0002666) | 1.71649381 |
| 171 | Rapidly progressive (HP:0003678) | 1.70898561 |
| 172 | Pulmonary infiltrates (HP:0002113) | 1.70265186 |
| 173 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.68008460 |
| 174 | Interstitial pulmonary disease (HP:0006530) | 1.66501904 |
| 175 | Difficulty climbing stairs (HP:0003551) | 1.66132165 |
| 176 | Resting tremor (HP:0002322) | 1.65319318 |
| 177 | Protrusio acetabuli (HP:0003179) | 1.65072756 |
| 178 | Annular pancreas (HP:0001734) | 1.63563602 |
| 179 | Osteomyelitis (HP:0002754) | 1.62065486 |
| 180 | Leukocytosis (HP:0001974) | 1.60515553 |
| 181 | Mitral stenosis (HP:0001718) | 1.58346509 |
| 182 | Recurrent cutaneous fungal infections (HP:0011370) | 1.57903281 |
| 183 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.57903281 |
| 184 | Acne (HP:0001061) | 1.57604954 |
| 185 | Broad face (HP:0000283) | 1.56266497 |
| 186 | T lymphocytopenia (HP:0005403) | 1.54345341 |
| 187 | Dysostosis multiplex (HP:0000943) | 1.50941226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.35642649 |
| 2 | NTRK3 | 3.78768320 |
| 3 | MAP3K9 | 2.87133341 |
| 4 | MAP2K3 | 2.62890498 |
| 5 | NTRK2 | 2.62275017 |
| 6 | DAPK2 | 2.60052656 |
| 7 | MAP3K4 | 2.57094273 |
| 8 | MARK1 | 2.53529563 |
| 9 | TNIK | 2.45227193 |
| 10 | PAK6 | 2.30203712 |
| 11 | PNCK | 2.26454765 |
| 12 | MAP2K7 | 2.25936474 |
| 13 | ERN1 | 2.22563131 |
| 14 | MAP3K3 | 2.09238035 |
| 15 | MINK1 | 2.06103510 |
| 16 | BLK | 2.06039262 |
| 17 | TRIB3 | 2.05545152 |
| 18 | CASK | 1.93459118 |
| 19 | IRAK4 | 1.91660381 |
| 20 | CSK | 1.89702203 |
| 21 | OXSR1 | 1.89047790 |
| 22 | NTRK1 | 1.81428088 |
| 23 | PRKD3 | 1.76394515 |
| 24 | TAOK1 | 1.73324695 |
| 25 | PRPF4B | 1.69184710 |
| 26 | TYK2 | 1.67967027 |
| 27 | STK39 | 1.67720770 |
| 28 | MAP2K4 | 1.65782664 |
| 29 | CDK5 | 1.63947011 |
| 30 | RIPK4 | 1.63631057 |
| 31 | ZAP70 | 1.58510456 |
| 32 | GRK6 | 1.49440324 |
| 33 | CDK19 | 1.49279243 |
| 34 | RIPK1 | 1.48526568 |
| 35 | MAP4K1 | 1.42952550 |
| 36 | MAP3K11 | 1.37119982 |
| 37 | CAMKK1 | 1.36336072 |
| 38 | KSR2 | 1.34796435 |
| 39 | MAPK13 | 1.31961082 |
| 40 | FES | 1.31527804 |
| 41 | MAP3K12 | 1.31518247 |
| 42 | PRKD2 | 1.25194424 |
| 43 | CSNK1G2 | 1.25086330 |
| 44 | HCK | 1.23575865 |
| 45 | SGK494 | 1.22514822 |
| 46 | SGK223 | 1.22514822 |
| 47 | PLK2 | 1.21979166 |
| 48 | STK38 | 1.20796101 |
| 49 | DAPK1 | 1.19430018 |
| 50 | IRAK2 | 1.18530178 |
| 51 | TYRO3 | 1.18184914 |
| 52 | SIK1 | 1.15215607 |
| 53 | CAMK1G | 1.14061860 |
| 54 | MAP3K6 | 1.13373100 |
| 55 | JAK2 | 1.11602401 |
| 56 | JAK3 | 1.11492616 |
| 57 | PKN1 | 1.11283043 |
| 58 | SIK2 | 1.11142540 |
| 59 | JAK1 | 1.10768530 |
| 60 | WNK1 | 1.09091562 |
| 61 | UHMK1 | 1.09062446 |
| 62 | CAMK2A | 1.06045557 |
| 63 | MAP3K13 | 1.05514555 |
| 64 | KSR1 | 1.05104689 |
| 65 | ICK | 1.04876050 |
| 66 | NEK6 | 1.04300800 |
| 67 | GRK5 | 1.03633671 |
| 68 | STK11 | 1.03558108 |
| 69 | CSNK1A1L | 1.03411374 |
| 70 | PHKG1 | 1.01150432 |
| 71 | PHKG2 | 1.01150432 |
| 72 | PRKCG | 1.00295138 |
| 73 | MARK2 | 0.99985390 |
| 74 | CDK12 | 0.98719615 |
| 75 | FGR | 0.98465205 |
| 76 | CSNK1G3 | 0.95917038 |
| 77 | BTK | 0.95811607 |
| 78 | CAMK2B | 0.95450524 |
| 79 | TTN | 0.92686851 |
| 80 | BMPR2 | 0.92186075 |
| 81 | MAP3K2 | 0.91715726 |
| 82 | TNK2 | 0.89079810 |
| 83 | MAPK12 | 0.88769981 |
| 84 | FGFR2 | 0.88387344 |
| 85 | PTK6 | 0.88002327 |
| 86 | IRAK1 | 0.87921921 |
| 87 | SYK | 0.87851399 |
| 88 | ARAF | 0.85611283 |
| 89 | CAMK1 | 0.85333688 |
| 90 | PRKCH | 0.83683116 |
| 91 | SGK2 | 0.82175075 |
| 92 | PAK3 | 0.79163596 |
| 93 | FGFR4 | 0.78467593 |
| 94 | SGK1 | 0.76958760 |
| 95 | FGFR3 | 0.76385645 |
| 96 | SGK3 | 0.76238266 |
| 97 | YES1 | 0.76209553 |
| 98 | CDK15 | 0.75516641 |
| 99 | CDK18 | 0.74314501 |
| 100 | MAP3K7 | 0.72873004 |
| 101 | FER | 0.71799570 |
| 102 | TAOK2 | 0.70983574 |
| 103 | PIK3CG | 0.70865450 |
| 104 | NEK1 | 0.70389515 |
| 105 | PINK1 | 0.69603530 |
| 106 | CDK14 | 0.68542746 |
| 107 | PDGFRB | 0.67815783 |
| 108 | CAMK2D | 0.67655369 |
| 109 | PTK2B | 0.67618205 |
| 110 | PRKD1 | 0.65554177 |
| 111 | EPHA3 | 0.65247459 |
| 112 | DYRK1A | 0.64598218 |
| 113 | MARK3 | 0.64421843 |
| 114 | BMX | 0.63905143 |
| 115 | FYN | 0.63568580 |
| 116 | PDPK1 | 0.62733969 |
| 117 | PDK1 | 0.62512015 |
| 118 | TBK1 | 0.62318625 |
| 119 | CSNK1G1 | 0.62279909 |
| 120 | CDK11A | 0.61562802 |
| 121 | PKN2 | 0.60992480 |
| 122 | IKBKE | 0.60456092 |
| 123 | ROCK2 | 0.58686382 |
| 124 | RET | 0.56493919 |
| 125 | RPS6KA2 | 0.56393637 |
| 126 | PRKCE | 0.56236667 |
| 127 | MAPK7 | 0.55578787 |
| 128 | CSF1R | 0.55398327 |
| 129 | TGFBR2 | 0.55104702 |
| 130 | BCR | 0.54692522 |
| 131 | PRKG2 | 0.54143985 |
| 132 | DYRK1B | 0.53852066 |
| 133 | LYN | 0.53370022 |
| 134 | MAPK10 | 0.51993667 |
| 135 | CAMK2G | 0.51695387 |
| 136 | WNK4 | 0.50575201 |
| 137 | SMG1 | 0.50507046 |
| 138 | CDC42BPA | 0.49218146 |
| 139 | MAP3K5 | 0.47922826 |
| 140 | PTK2 | 0.46502536 |
| 141 | RPS6KA3 | 0.46502220 |
| 142 | LCK | 0.44701339 |
| 143 | ALK | 0.44538561 |
| 144 | MAPKAPK5 | 0.43336443 |
| 145 | PRKCZ | 0.40957302 |
| 146 | DDR2 | 0.38297155 |
| 147 | PRKG1 | 0.36548746 |
| 148 | MAP3K1 | 0.36315768 |
| 149 | PRKCQ | 0.35571847 |
| 150 | EPHB1 | 0.34773311 |
| 151 | RAF1 | 0.34545767 |
| 152 | CAMKK2 | 0.34159059 |
| 153 | CAMK4 | 0.33453409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.51461914 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.98077116 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72845471 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66763806 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66388489 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65976056 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.60820946 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.53743299 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.50021735 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.23957929 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.15064007 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.02457643 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.02191498 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00642679 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85580477 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84113325 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76884138 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75019040 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.72816437 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.67847948 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.64968698 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.63730350 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.62264552 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58902665 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57660763 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56155296 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51189615 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49816323 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.46670112 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44441048 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.41361420 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40902350 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38069772 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34314641 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33098398 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31959968 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31632594 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31358823 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.30759714 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29561217 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29389966 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29328849 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.28230086 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.27703897 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.25325002 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.24723723 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24578254 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24262413 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20683071 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13600904 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13046927 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11627480 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09581172 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08915531 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 1.06551251 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04867658 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04017625 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02654705 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99690985 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98705197 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98649936 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.98181405 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97513469 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97254191 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97168070 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96344705 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96227002 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94201748 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93574446 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92687060 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.91703285 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91370315 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91339805 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.89453943 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89434941 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89305067 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.89151090 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.88282458 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87441349 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.86848399 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85794548 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83904353 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82880356 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82666510 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81317614 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.80900240 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79814403 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79174033 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.78782398 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77068846 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76896746 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76407864 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75700025 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74333255 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74151328 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73768430 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.72255717 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71444740 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70610920 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69449082 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68373252 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.67732066 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66624414 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.65603197 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64544538 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64081698 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.63573222 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61804053 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60593689 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56140226 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55744128 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55722448 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52544943 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51777910 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.51117960 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47973706 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47878034 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47791659 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47335706 |
| 120 | Bile secretion_Homo sapiens_hsa04976 | 0.46450832 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46197131 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45904869 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45618173 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45276295 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45195047 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.43780633 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42300527 |
| 128 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42190109 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40144614 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39167049 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38077821 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37633097 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37017035 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36123213 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35136899 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.33751903 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32663664 |
| 138 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30642351 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30259337 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29913165 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28899221 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28566877 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.28179890 |
| 144 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27516072 |

